S&P 500   3,000.79 (-0.20%)
DOW   26,841.17 (+0.05%)
QQQ   192.21 (-0.61%)
AAPL   240.49 (+-0.01%)
FB   183.22 (-3.45%)
MSFT   136.90 (-1.11%)
GOOGL   1,240.36 (-0.32%)
AMZN   1,765.58 (-1.12%)
NVDA   196.33 (+0.16%)
MU   44.71 (-1.13%)
BABA   169.61 (-2.25%)
GE   8.96 (+1.93%)
TSLA   256.33 (+1.12%)
AMD   31.56 (-1.50%)
T   38.24 (+0.03%)
F   9.06 (+0.33%)
ACB   3.59 (-2.71%)
PRI   125.72 (+0.02%)
NFLX   266.85 (-4.03%)
BAC   31.19 (+0.52%)
GILD   66.06 (+1.30%)
DIS   132.81 (+1.96%)
S&P 500   3,000.79 (-0.20%)
DOW   26,841.17 (+0.05%)
QQQ   192.21 (-0.61%)
AAPL   240.49 (+-0.01%)
FB   183.22 (-3.45%)
MSFT   136.90 (-1.11%)
GOOGL   1,240.36 (-0.32%)
AMZN   1,765.58 (-1.12%)
NVDA   196.33 (+0.16%)
MU   44.71 (-1.13%)
BABA   169.61 (-2.25%)
GE   8.96 (+1.93%)
TSLA   256.33 (+1.12%)
AMD   31.56 (-1.50%)
T   38.24 (+0.03%)
F   9.06 (+0.33%)
ACB   3.59 (-2.71%)
PRI   125.72 (+0.02%)
NFLX   266.85 (-4.03%)
BAC   31.19 (+0.52%)
GILD   66.06 (+1.30%)
DIS   132.81 (+1.96%)
Log in

Bausch Health Companies Stock Price, News & Analysis (TSE:BHC)

C$29.72
-0.18 (-0.60 %)
(As of 10/22/2019 03:20 PM ET)
Today's Range
C$29.52
Now: C$29.72
C$30.24
50-Day Range
C$25.43
MA: C$28.58
C$31.04
52-Week Range
C$23.60
Now: C$29.72
C$36.32
Volume337,010 shs
Average Volume782,824 shs
Market CapitalizationC$10.47 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. was founded in 1983 and is headquartered in Laval, Canada.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone514-744-6792

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$8.42 billion
Cash FlowC$2.46 per share
Book ValueC$7.38 per share

Profitability

Miscellaneous

Employees21,100
Market CapC$10.47 billion
Next Earnings Date11/4/2019 (Confirmed)
OptionableOptionable

Receive BHC News and Ratings via Email

Sign-up to receive the latest news and ratings for BHC and its competitors with MarketBeat's FREE daily newsletter.


Bausch Health Companies (TSE:BHC) Frequently Asked Questions

What is Bausch Health Companies' stock symbol?

Bausch Health Companies trades on the Toronto Stock Exchange (TSX) under the ticker symbol "BHC."

How were Bausch Health Companies' earnings last quarter?

Bausch Health Companies Inc (TSE:BHC) released its earnings results on Tuesday, August, 6th. The company reported $1.38 EPS for the quarter, missing analysts' consensus estimates of $1.42 by $0.04. The business earned $2.88 billion during the quarter, compared to the consensus estimate of $2.89 billion. View Bausch Health Companies' Earnings History.

When is Bausch Health Companies' next earnings date?

Bausch Health Companies is scheduled to release their next quarterly earnings announcement on Monday, November 4th 2019. View Earnings Estimates for Bausch Health Companies.

What price target have analysts set for BHC?

0 brokers have issued twelve-month target prices for Bausch Health Companies' stock. Their forecasts range from C$25.00 to C$28.00. On average, they anticipate Bausch Health Companies' share price to reach C$26.50 in the next twelve months. This suggests that the stock has a possible downside of 10.8%. View Analyst Price Targets for Bausch Health Companies.

Has Bausch Health Companies been receiving favorable news coverage?

Media headlines about BHC stock have been trending extremely negative on Tuesday, InfoTrie reports. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Bausch Health Companies earned a daily sentiment score of -4.3 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Bausch Health Companies.

Who are some of Bausch Health Companies' key competitors?

What other stocks do shareholders of Bausch Health Companies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bausch Health Companies investors own include Chesapeake Energy (CHK), VolitionRX (VNRX), Bank of Nova Scotia (BNS), Aurora Cannabis (ACB), Bank of Nova Scotia (BNS), General Electric (GE), Athabasca Oil (ATH), Baytex Energy (BTE), CES Energy Solutions (CEU) and Hudbay Minerals (HBM).

Who are Bausch Health Companies' key executives?

Bausch Health Companies' management team includes the folowing people:
  • Mr. Joseph C. Papa, CEO & Chairman (Age 64)
  • Mr. Paul S. Herendeen, Exec. VP & CFO (Age 63)
  • Ms. Christina M. Ackermann, Exec. VP & Gen. Counsel (Age 54)
  • Mr. Thomas J. Appio, Pres & Co-Head Bausch + Lomb/International (Age 57)
  • Mr. Joseph Gordon, Pres & Co-Head Bausch + Lomb/International (Age 55)

How do I buy shares of Bausch Health Companies?

Shares of BHC and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Bausch Health Companies' stock price today?

One share of BHC stock can currently be purchased for approximately C$29.72.

How big of a company is Bausch Health Companies?

Bausch Health Companies has a market capitalization of C$10.47 billion and generates C$8.42 billion in revenue each year. Bausch Health Companies employs 21,100 workers across the globe.View Additional Information About Bausch Health Companies.

What is Bausch Health Companies' official website?

The official website for Bausch Health Companies is http://www.valeant.com/.

How can I contact Bausch Health Companies?

The company can be reached via phone at 514-744-6792.


MarketBeat Community Rating for Bausch Health Companies (TSE BHC)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  22 (Vote Outperform)
Underperform Votes:  23 (Vote Underperform)
Total Votes:  45
MarketBeat's community ratings are surveys of what our community members think about Bausch Health Companies and other stocks. Vote "Outperform" if you believe BHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/22/2019 by MarketBeat.com Staff

Featured Article: What is the Quick Ratio?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel